Agios Pharmaceuticals
AGIO
AGIO
152 hedge funds and large institutions have $1.68B invested in Agios Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
56% less call options, than puts
Call options by funds: $5.2M | Put options by funds: $11.9M
Holders
152
Holding in Top 10
1
Calls
$5.2M
Puts
$11.9M
Top Buyers
| 1 | +$36.7M | |
| 2 | +$16.9M | |
| 3 | +$9.15M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$5.28M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.09M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$13.3M | |
| 3 | -$5.81M | |
| 4 |
AC
Armistice Capital
New York
|
-$5.78M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$4.89M |